- NTDs thrive under conditions of poverty, poor sanitation, unsafe water, and malnutrition
- NTDs can blind, deform, and debilitate their victims
- NTDs compromise mental and physical development, reduce school enrollment, and hinder economic productivity
- Preventing NTDs attacks a root cause of poverty that affects a significant proportion of the world’s population
- Safe and effective drugs are now available to prevent the most common NTDs
About the NTD Program
USAID is a global leader in the large-scale implementation of integrated treatment programs for NTDs, focusing on mass drug administration to target the control and/or elimination of the diseases.
Learn more ▶
Latest NewsGo to Newsroom
The Liverpool School of Tropical Medicine Announces £3 Billion Ross Fund to Support the Global Fight Against Infectious Diseases
Along with the support for malaria and other infectious diseases, the fund will allocate £200 million to Neglected Tropical Diseases (NTDs) and over £300 million fighting antimicrobial resistance.
Video: Global Trachoma Mapping Project
USAID is a partner in the Global Trachoma Mapping Project, the largest mapping project in history. By the time the project ends in 2015, it will have mapped the global prevalence of trachoma in three years.
Bringing NTDs into Sharp Focus: A Joint Vision for Better Sight in Ethiopia
Devex provides a closer look at the global fight against NTDs through a series of exclusive interviews with partners, including USAID, working on the frontlines of NTD control and elimination efforts in Ethiopia.
VOA's Africa 54 News Highlights Nobel Prize Winners
Voice of America's Africa 54 News highlights the work of the recent Nobel Prize winners who discovered therapies to treat some of the most devastating parasitic diseases in the world.
3 Scientists Win Nobel Prize in Medicine for Parasite-Fighting Therapies
Three scientists were awarded the Nobel Prize in Physiology or Medicine for discovering therapies to treat some of the most devastating parasitic diseases in the world. Their award-winning therapies include Ivermectin, which USAID utilizes to help combat river blindness and filariasis.
New Information on Merck Mectizan Donation Program Available
USAID pharmaceutical partner Merck has new information available regarding their Mectizan donation program. Mectizan is used to curb onchoceriasis and lymphatic filariasis throughout the Americas.
A Great New Partnership to Expand Access to Filiaris Test Strips
A new diagnostic test enabling countries to determine when to stop large-scale treatment of populations to eliminate lymphatic filariasis is now available. The Filariasis Test Strip is a new point-of-care rapid diagnostic test designed to detect in human blood the antigen of the major species of filarial worm that causes lymphatic filariasis.
Global Partners Celebrate the Donation of 500 Millionth Dose of Zithromax®
The International Trachoma Initiative,Pfizer, Inc., and the International Coalition for Trachoma Control celebrate Pfizer's donation of the 500 millionth dose of Zithromax®, a critical antibiotic used to prevent and treat trachoma.
One Billion and Counting: Accelerating Action to Eliminate NTDs by 2020
Learn more about the One Billion and Counting campaign highlighting the success of USAID’s NTD program.
Read more about the campaign.
Uniting to Combat NTDs: 2020 Goals
Uniting efforts with NTD-endemic countries, partners pledged to bring a unique focus to defeating these diseases and to work together to improve the lives of the 1.4 billion people worldwide affected by NTDs.
USAID collaborates with a wide range of partners to implement the NTD Program.